On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity

Area of Science:

• Hematology
• Immunology
• Biochemistry

Background:

• The terminal complement pathway involves the assembly of the membrane attack complex (MAC, C5b-9).
• Platelets play a crucial role in hemostasis and thrombosis, interacting with complement proteins.
• The precise mechanisms by which MAC influences platelet function, particularly coagulation, are not fully elucidated.

Purpose of the Study:

• To investigate the effect of MAC assembly on human platelets.
• To determine how MAC influences the binding of coagulation factors Va and Xa to platelets.
• To assess the impact of MAC on platelet prothrombinase activity and alpha-granule release.

Main Methods:

• Treatment of human platelets with purified C5b-9 proteins.
• Quantification of coagulation factor Va and Xa binding to platelet surfaces using assays.
• Measurement of platelet prothrombinase activity.
• Assay for platelet factor 4 release to confirm alpha-granule release.
• Investigation of the role of calcium ions (Ca2+) in C5b-9-mediated effects.

Main Results:

• C5b-9 assembly on platelets dose-dependently increased the binding of coagulation factors Va and Xa.
• Factor Va binding increased 6-15 fold, and factor Xa binding increased significantly, suggesting C5b-9 initiates factor V release from alpha-granules.
• Platelet prothrombinase activity was markedly increased on C5b-9-treated platelets.
• C5b-9 induced non-lytic release of platelet alpha-granules, confirmed by platelet factor 4 release.
• Removal of external Ca2+ inhibited alpha-granule release and reduced new factor Va binding sites, indicating calcium influx is involved.

Conclusions:

• Membrane assembly of C5b-9 on human platelets significantly enhances prothrombinase activity.
• C5b-9 triggers the release of platelet factor V from alpha-granules and increases factor Xa binding, partly mediated by calcium influx.
• These findings highlight a novel interaction between the complement and coagulation systems at the platelet level.